Inolitazone Dihydrochloride
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Inolitazone Dihydrochloride, covering 2019-12-27 to 2019-12-27. Get the full timeline:
Most recent: Clinical Trial Update: Inolitazone Dihydrochloride and Paclitaxel in Treating Patients With Advanced Anaplastic Thyroid Cancer [Phase 2]